Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B

It remains controversial whether entecavir (ETV) and tenofovir disoproxil fumarate (TDF) is associated with different clinical outcomes for chronic hepatitis B (CHB). This study aimed to compare the long-term risk of ETV versus TDF on hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Te-Sheng, Yang, Yao-Hsu, Chen, Wei-Ming, Shen, Chien-Heng, Tung, Shui-Yi, Yen, Chih-Wei, Hsieh, Yung-Yu, Lee, Chuan-Pin, Tsai, Meng-Ling, Hung, Chao-Hung, Lu, Sheng-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809351/
https://www.ncbi.nlm.nih.gov/pubmed/33446835
http://dx.doi.org/10.1038/s41598-020-80523-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809351/
https://www.ncbi.nlm.nih.gov/pubmed/33446835
http://dx.doi.org/10.1038/s41598-020-80523-7

Ejemplares similares